← Open Payments lookup

KAMAN LINDGREN: Open Payments

NPI 1811522766 · LACEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 15 payments from 8 companies in 2025. Trend: 2023 $748 · 2024 $1,251 · 2025 $1,209

Food & beverage: $1,131Education: $78
CompanyPaymentsAmount
Janssen Biotech, Inc.6$630
Adaptive Biotechnologies Corporation1$163
Alnylam Pharmaceuticals Inc.1$121
Takeda Pharmaceuticals U.S.A., Inc.1$89
ABBVIE INC.3$88
Regeneron Healthcare Solutions, Inc.1$81
BeiGene USA, Inc.1$20
AstraZeneca Pharmaceuticals LP1$18

Products named: RYBREVANT, clonoSEQ, GIVLAARI, FRUZAQLA, EPKINLY, LIBTAYO, ERLEADA, BRUKINSA.

Industry payments across WA — which companies pay providers there.